Explore the categories so you can find more about your search.

Categorie > Bipolar

New Mouse Model Of Bipolar Disorder

Categorie : Bipolar
Bipolar Disorder (BPD or manic-depressive illness) is one of the most serious of all mental disorders, affecting millions of individuals worldwide. Affected individuals alternate between states of deep depression and mania. While depression is characterized by persistent and long-term sadness or des ...

read more Bipolar Disorder (BPD or manic-depressive illness) is one of the most serious of all mental disorders, affecting millions of individuals worldwide. Affected individuals alternate between states of deep depression and mania. While depression is characterized by persistent and long-term sadness or des read more Wed Mar 2008 Wed Mar 2008

New Clues For Uncovering The Mysteries Of Mental Illness

Categorie : Bipolar
Scientists have discovered epigenetic changes (i.e. chemical changes to a gene that do not alter the DNA sequence) in individuals with schizophrenia and bipolar disorder. This is the first epigenome-wide investigation in psychiatric research, and this groundbreaking data may be a significant step o ...

read more Scientists have discovered epigenetic changes (i.e. chemical changes to a gene that do not alter the DNA sequence) in individuals with schizophrenia and bipolar disorder. This is the first epigenome-wide investigation in psychiatric research, and this groundbreaking data may be a significant step o read more Wed Mar 2008 Wed Mar 2008

Breast Cancer Drug Tamoxifen May Decrease Mania Of Bipolar Disorder

Categorie : Bipolar
The drug tamoxifen is usually used to treat breast cancer, butresearchers say that it also may reduce symptoms of mania in peoplewith bipolar disorder. An article summarizing the small, three-weektrial of tamoxifen is published in Archives of GeneralPsychiatry.As a treatment for breast cancer, tamox ...

read more The drug tamoxifen is usually used to treat breast cancer, butresearchers say that it also may reduce symptoms of mania in peoplewith bipolar disorder. An article summarizing the small, three-weektrial of tamoxifen is published in Archives of GeneralPsychiatry.As a treatment for breast cancer, tamox read more Thu Mar 2008 Thu Mar 2008

ABILIFY Approved For Acute Treatment Of Bipolar I Disorder In Patients 10 To 17 Years Old

Categorie : Bipolar
Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company (NYSE: BMY) has announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application for ABILIFYŽ (aripiprazole) for the acute treatment of manic and mixed episodes associated with Bipolar I Disorde ...

read more Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company (NYSE: BMY) has announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application for ABILIFYŽ (aripiprazole) for the acute treatment of manic and mixed episodes associated with Bipolar I Disorde read more Tue Mar 2008 Tue Mar 2008

Indiana U Study May Alter Approach To Psychiatric Treatment

Categorie : Bipolar
Indiana University School of Medicine researchers have isolated biomarkers in the blood that identify mood disorders, a breakthrough that may change the way bipolar illness is diagnosed and treated. The report will be published in the February 26 advance online edition of the journal Molecular Psych ...

read more Indiana University School of Medicine researchers have isolated biomarkers in the blood that identify mood disorders, a breakthrough that may change the way bipolar illness is diagnosed and treated. The report will be published in the February 26 advance online edition of the journal Molecular Psych read more Fri Feb 2008 Fri Feb 2008

Alexza Initiates First Phase 3 Clinical Trial For AZ-004 (Staccato(R) Loxapine)

Categorie : Bipolar
Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced that it has initiated its first Phase 3 clinical trial with AZ-004 (Staccato(R) loxapine). AZ-004 is an inhalation product candidate being developed for the treatment of acute agitation in patients with schizophrenia or bipolar disorder. ...

read more Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced that it has initiated its first Phase 3 clinical trial with AZ-004 (Staccato(R) loxapine). AZ-004 is an inhalation product candidate being developed for the treatment of acute agitation in patients with schizophrenia or bipolar disorder. read more Fri Feb 2008 Fri Feb 2008

Bipolar Depression Licence Application For Seroquel(R)

Categorie : Bipolar
AstraZeneca has submitted an application to the Medicines and Healthcare products Regulatory Agency (MHRA) for a new licence for Seroquel(R) (quetiapine fumarate) in the UK for major depressive episodes in the framework of bipolar disorder. Quetiapine is currently licensed in the UK for the treatmen ...

read more AstraZeneca has submitted an application to the Medicines and Healthcare products Regulatory Agency (MHRA) for a new licence for Seroquel(R) (quetiapine fumarate) in the UK for major depressive episodes in the framework of bipolar disorder. Quetiapine is currently licensed in the UK for the treatmen read more Fri Feb 2008 Fri Feb 2008

Astrazeneca Submits Seroquel XR For The Treatment Of Bipolar Mania And Bipolar Depression, And Seroquel(R) For The Treatment Of Bipolar Depression

Categorie : Bipolar
AstraZeneca announced that the company has submitted applications in the European Union (EU) under the Mutual Recognition Procedure (MRP) for once-daily SEROQUEL XR(TM) (quetiapine fumarate) Extended-Release Tablets, seeking approval for the treatment of manic episodes associated with bipolar disord ...

read more AstraZeneca announced that the company has submitted applications in the European Union (EU) under the Mutual Recognition Procedure (MRP) for once-daily SEROQUEL XR(TM) (quetiapine fumarate) Extended-Release Tablets, seeking approval for the treatment of manic episodes associated with bipolar disord read more Tue Feb 2008 Tue Feb 2008

Study Suggests Risperidone Long-Acting Injection Combined With Standard Treatment Helped Delay Time To Relapse In Patients With Bipolar Disorder

Categorie : Bipolar
Patients with frequently relapsing bipolar disorder had a significant delay in the time to an initial relapse when risperidone long-acting injection (RLAI) was combined with standard treatment, according to a new study. The study compared patients who received RLAI and standard treatment to those w ...

read more Patients with frequently relapsing bipolar disorder had a significant delay in the time to an initial relapse when risperidone long-acting injection (RLAI) was combined with standard treatment, according to a new study. The study compared patients who received RLAI and standard treatment to those w read more Tue Feb 2008 Tue Feb 2008

ACADIA Announces Presentation Of Data On Pimavanserin Co-Therapy At The 14th Biennial Winter Workshop On On Schizophrenia And Bipolar Disorders

Categorie : Bipolar
ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that Murray Rosenthal, D.O. ...

read more ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that Murray Rosenthal, D.O. read more Tue Feb 2008 Tue Feb 2008

Scientists Discover Chemical Signature Of Manic Depression

Categorie : Bipolar
People with manic depression have a distinct chemical signature in their brains, according to a new study. The research, published in the journal Molecular Psychiatry, may also indicate how the mood stabilisers used to treat the disorder counteract the changes in the brain that it appears to cause. ...

read more People with manic depression have a distinct chemical signature in their brains, according to a new study. The research, published in the journal Molecular Psychiatry, may also indicate how the mood stabilisers used to treat the disorder counteract the changes in the brain that it appears to cause. read more Tue Feb 2008 Tue Feb 2008

Study Suggests Risperidone Long Acting Injection Combined With Standard Treatment Helped Delay Time To Relapse In Patients With Bipolar Disorder

Categorie : Bipolar
Patients with frequently relapsing bipolar disorder had a significant delay in the time to an initial relapse when risperidone long-acting injection (RLAI) was combined with standard treatment, according to a new study. The study compared patients who received RLAI and standard treatment to those w ...

read more Patients with frequently relapsing bipolar disorder had a significant delay in the time to an initial relapse when risperidone long-acting injection (RLAI) was combined with standard treatment, according to a new study. The study compared patients who received RLAI and standard treatment to those w read more Tue Feb 2008 Tue Feb 2008

Analysis of Chinese Engineering Machine Market in 2006 and Its Prediction in 2007

Categorie : Bipolar
1. China machine market review in 2007 In 2007 engineering machine state of business under national implementation macroeconomic regulation and control situation, and in the last few years the growth rate of China engineering machine is lowest between 2005 May to the end of ...

read more 1. China machine market review in 2007 In 2007 engineering machine state of business under national implementation macroeconomic regulation and control situation, and in the last few years the growth rate of China engineering machine is lowest between 2005 May to the end of read more Sat Feb 2008 Sat Feb 2008

New Analysis Demonstrates Efficacy Of Seroquel (Quetiapine Fumarate) Maintenance Treatment For Bipolar I Disorder

Categorie : Bipolar
Results from a combined analysis of two long term phase III clinical trials2,3 have shown that patients with bipolar I disorder who received treatment with quetiapine plus a mood stabiliser showed a 70% reduction in the risk of recurrence of a mood event (manic, mixed or depressed) compared to patie ...

read more Results from a combined analysis of two long term phase III clinical trials2,3 have shown that patients with bipolar I disorder who received treatment with quetiapine plus a mood stabiliser showed a 70% reduction in the risk of recurrence of a mood event (manic, mixed or depressed) compared to patie read more Thu Jan 2008 Thu Jan 2008

New Analysis Highlights Potential Of SEROQUEL For Long-term Treatment Of Bipolar Disorder

Categorie : Bipolar
Results from a new analysis of two major clinical trials have shown that patients with bipolar disorder who received long-term treatment with SEROQUEL (quetiapine fumarate) plus a mood stabiliser were significantly less likely to have a mood event (manic, mixed or depressed) than patients on a mood ...

read more Results from a new analysis of two major clinical trials have shown that patients with bipolar disorder who received long-term treatment with SEROQUEL (quetiapine fumarate) plus a mood stabiliser were significantly less likely to have a mood event (manic, mixed or depressed) than patients on a mood read more Thu Jan 2008 Thu Jan 2008

Psychological Interventions Are Effective In Mood Swings

Categorie : Bipolar
Jan Scott (Newcastle, UK) and Francesc Colom (Barcelona) have published a review of psychological interventions for bipolar disorder in the Jan 2008 issue of Psychotherapy and Psychosomatics.The aim of this review was to highlight gaps or limitations in applying evidence-based psychological therapie ...

read more Jan Scott (Newcastle, UK) and Francesc Colom (Barcelona) have published a review of psychological interventions for bipolar disorder in the Jan 2008 issue of Psychotherapy and Psychosomatics.The aim of this review was to highlight gaps or limitations in applying evidence-based psychological therapie read more Sat Jan 2008 Sat Jan 2008

New Report Dispels Greatest Myths About Bipolar Disorder

Categorie : Bipolar
New free report reveals that many individuals misunderstand bipolar disorder and have bought into "bipolar lies." David Oliver, founder of Bipolar Central, has recently released a free report that uncovers and dispels various widely circulated myths about bipolar disorder. The report, entitled "10 G ...

read more New free report reveals that many individuals misunderstand bipolar disorder and have bought into read more Mon Jan 2008 Mon Jan 2008

Most Psychiatric Patients Have More Than 1 Diagnosis, Study Finds

Categorie : Bipolar
A new study by Rhode Island Hospital researchers reports that the majority of 2,300 psychiatry outpatients had more than one disorder when seeking treatment, and more than one-third had at least three disorders. The study is published in the February 2008 edition of the journal Psychological Medicin ...

read more A new study by Rhode Island Hospital researchers reports that the majority of 2,300 psychiatry outpatients had more than one disorder when seeking treatment, and more than one-third had at least three disorders. The study is published in the February 2008 edition of the journal Psychological Medicin read more Mon Jan 2008 Mon Jan 2008

Astrazeneca Submits Supplemental New Drug Applications For Seroquel XR For The Treatment Of Bipolar Mania And Bipolar Depression

Categorie : Bipolar
AstraZeneca announced that the company has submitted two separate supplemental New Drug Applications (sNDAs) to the U.S. Food and Drug Administration (FDA) for once-daily SEROQUEL XR? (quetiapine fumarate) Extended-Release Tablets to seek approval for the treatment of manic episodes associated with ...

read more AstraZeneca announced that the company has submitted two separate supplemental New Drug Applications (sNDAs) to the U.S. Food and Drug Administration (FDA) for once-daily SEROQUEL XR? (quetiapine fumarate) Extended-Release Tablets to seek approval for the treatment of manic episodes associated with read more Mon Jan 2008 Mon Jan 2008

Some Women With Bipolar Depression Benefit From Bright Light

Categorie : Bipolar
Bright light therapy can ease bipolar depression in some patients, according to a study published in the journal Bipolar Disorders. Researchers from the University of Pittsburgh School of Medicine's Western Psychiatric Institute and Clinic studied nine women with bipolar disorder to examine the effe ...

read more Bright light therapy can ease bipolar depression in some patients, according to a study published in the journal Bipolar Disorders. Researchers from the University of Pittsburgh School of Medicine's Western Psychiatric Institute and Clinic studied nine women with bipolar disorder to examine the effe read more Mon Jan 2008 Mon Jan 2008

<<< previous | 1 | 2 | 3 | 4 | 5 next >>>



     


Custom Search